Amy leads research and development at Life Edit Therapeutics. She has more than 20 years of scientific leadership and expertise with an extensive background in genetic medicine, neuroscience, drug development, and scientific strategy.
Prior to joining Life Edit, Amy held various leadership roles at Sangamo Therapeutics. She most recently served as Vice President, Head of Research where she helped establish multiple global licensing and R&D collaborations. She also built the neuroscience team and established an internal neurology pipeline, in addition to supporting multiple programs partnered with pharma companies.
Amy received her Ph.D. in Cellular and Molecular Neuroscience from the Massachusetts Institute of Technology and her B.S. in Neuroscience from Brown University.
